C.R. Bard, Inc. v. Medical Components, Inc., No. 22-1136 (Fed. Cir. Feb. 17, 2023)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Plaintiffs-Appellants C.R. Bard Inc. and Bard Peripheral Vascular, Inc. appeal a decision from the United States District Court for the District of Utah finding the asserted claims for three asserted patents ineligible under 35 U.S.C. § 101. Defendant -Cross-Appellant Medical Components, Inc. cross -appeals a decision from the same court, also finding the asserted claims of its asserted patent ineligible under § 101. Because the district court’s opinions are contrary to our binding precedent in C R Bard Inc. v.